Skip to content

Category

gene editing

1,414 papers

#gene editing Sep 2026

A new MRR1 gain-of-function mutation involved in cross-resistance to antifungal agents in the fungal priority pathogen Candida parapsilosis.

OBJECTIVES Candida parapsilosis is a leading cause of invasive candidiasis globally, with rising reports of fluconazole resistance threatening its clinical management. Among the mechanisms involved, gain-of-function mutations in the MRR1 gene have emerged as key drivers of antifungal resistance. We aimed to investigate...

Manon Cadeau, José Rivaldo de Lima, Alina Marcela-Sabou et al. · 0 citations
#gene editing Editorial Open access Sep 2026

Editorial: Emerging targeted and immunotherapeutic strategies in oncology: from solid tumors to hematologic malignancies

Cancer remains among the leading causes of death worldwide, with an estimated 20 million new cases and nearly 10 million deaths in 2022 and a burden projected to grow substantially over the coming decades [1]. The conceptual framework of cancer as a disease of dysregulated hallmark capabilities, sustained proliferation...

Ximena Maria Mureșan, Adrian Bogdan Tigu, Andrei Roman et al. · 0 citations
#gene editing Open access Sep 2026

Toward a Precision Cure for Chronic Hepatitis B: Convergence of RNA Silencing, Gene Editing, Immune-Reset Therapies, and Artificial Intelligence-Guided Diagnostics

Chronic hepatitis B virus (HBV) infection remains a major global health challenge, affecting over 250 million individuals and causing more than one million deaths annually from cirrhosis and hepatocellular carcinoma. Although current antiviral therapies effectively suppress viral replication, they rarely achieve a func...

Saniya Sanjaysinh Patil, Siddhi Shivaji Powar, Shruti Vilas Patil, Prathamesh Pundlik Khade · 0 citations
#gene editing Review Open access Sep 2026

Herbicide Resistance Genes in Crops: Mechanisms, Progress, and Future Perspectives

While previous reviews have largely focused on individual crops or single target-site mechanisms, the full-chain comparative landscape across major cereal crops remains unexplored. Here, we fill this critical gap by providing the first systematic, cross-crop comparative review that spans herbicide targets, resistance m...

Yong-Chao Guo, Xue-Xia Ma, Zi-Hang Li et al. · 0 citations
#gene editing Open access Sep 2026

Rhbg is dispensable for spermatogenesis but fine-tunes sperm motility trajectory during capacitation in mice.

Rhesus (Rh) family B glycoprotein (RHBG) is a conserved ammonium transporter of the Rhesus family with established roles in systemic acid-base regulation. Although Rh family members are expressed in the male reproductive tract, the physiological role of RHBG in spermatogenesis and sperm function remains unclear. To inv...

Guang-Qing Tan, Lu-Jie Chen, Ru-Xiang Yang et al. · 0 citations
#gene editing Open access Sep 2026

Targeting Covalently Closed Circular DNA (cccDNA): Emerging Therapeutic Strategies Toward a Functional Cure for Chronic Hepatitis B

Chronic HBV won't be resolved in the immediate future. Almost 300 million individuals live with it [1], as well as it causes roughly 820,000 deaths annually [1]—mainly due to conditions such as cirrhosis, liver failure, or liver cancer. The usual therapies, such as nucleos(t)ide analogues and pegylated interferon-alpha...

Ponuku Sandhya, Guduri Sathwika, Nuli Sai Vasavi Taruni, S.V. Saikumar · 0 citations
#gene editing Open access Sep 2026

Supplementary Datasets underlying analysis and results presented inCRISPR-enhanced assessment of variants of unknown significance nominates oncology therapeutic targets and drug repositioning opportunities. Savino et Al. 2026

The functional interpretation of infrequent somatic variants remains a challenge in cancer genomics. We developed CRISPR-VUS, a computational framework using public Cancer Dependency Map data to identify Dependency-Associated Mutations (DAMs) - somatic variants associated with increased dependency on their host genes -...

Francesco Iorio · 0 citations
#gene editing Open access Sep 2026

Vaccines, Drug Development, and Novel Therapeutic Strategies for Hepatitis: Current Advances and Future Perspectives

Despite remarkable progress in prevention and treatment, hepatitis is still one of the main drivers of chronic liver disease, liver cirrhosis and hepatocellular carcinoma and is a big public health problem worldwide. The hepatitis viruses A, B, C, D and E are responsible for the occurrence of viral hepatitis in million...

Bhushan H. Jogawe, Unnati K. Bhagade, Suraj D. Thakare · 0 citations
#gene editing Open access Sep 2026

Biomimetic Cell Membrane-Coated Nanocarriers for CRISPR-Cas9 Delivery: Recent Advances, Challenges and Future Perspectives

The CRISPR-Cas9 system revolutionized genome editing and is a very promising platform for the treatment of cancers, genetic disorders, and infections. Yet the clinical translation of CRISPR-Cas9 is hampered by some major bottlenecks related to delivery issues, such as fast degradation, poor cellular uptake, and immunog...

Tushar Ingle Shubhangi Lal · 0 citations
#gene editing Open access Sep 2026

Biomimetic Cell Membrane-Coated Nanocarriers for CRISPR-Cas9 Delivery: Recent Advances, Challenges and Future Perspectives

The CRISPR-Cas9 system revolutionized genome editing and is a very promising platform for the treatment of cancers, genetic disorders, and infections. Yet the clinical translation of CRISPR-Cas9 is hampered by some major bottlenecks related to delivery issues, such as fast degradation, poor cellular uptake, and immunog...

Tushar Ingle Shubhangi Lal · 0 citations
#gene editing Review Sep 2026

Worldviews and public attitudes toward gene-edited foods in Japan.

This study examines public attitudes toward gene-edited foods in Japan, focusing on how underlying worldviews shape these responses. Drawing on a national survey and a latent class segmentation model based on 23 worldview variables, we identify four distinct segments: Communitarian, Environmentalist, Governmentalist, a...

Tomiko Yamaguchi, 나일등 · 0 citations

From tech blogs

See all →
Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.